IBEX (IBEX) Competitors $29.43 -0.10 (-0.34%) As of 03:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IBEX vs. GDRX, FLYW, TASK, DFIN, NVEE, GB, STGW, UPBD, PLTK, and CRTOShould you be buying IBEX stock or one of its competitors? The main competitors of IBEX include GoodRx (GDRX), Flywire (FLYW), TaskUs (TASK), Donnelley Financial Solutions (DFIN), NV5 Global (NVEE), Global Blue Group (GB), Stagwell (STGW), Upbound Group (UPBD), Playtika (PLTK), and Criteo (CRTO). These companies are all part of the "business services" industry. IBEX vs. Its Competitors GoodRx Flywire TaskUs Donnelley Financial Solutions NV5 Global Global Blue Group Stagwell Upbound Group Playtika Criteo GoodRx (NASDAQ:GDRX) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Does the media favor GDRX or IBEX? In the previous week, IBEX had 5 more articles in the media than GoodRx. MarketBeat recorded 12 mentions for IBEX and 7 mentions for GoodRx. GoodRx's average media sentiment score of 1.12 beat IBEX's score of 0.89 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IBEX 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GDRX or IBEX more profitable? IBEX has a net margin of 6.93% compared to GoodRx's net margin of 4.33%. IBEX's return on equity of 25.51% beat GoodRx's return on equity.Company Net Margins Return on Equity Return on Assets GoodRx4.33% 8.86% 4.50% IBEX 6.93%25.51%12.67% Which has stronger valuation & earnings, GDRX or IBEX? IBEX has lower revenue, but higher earnings than GoodRx. IBEX is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGoodRx$799.87M1.87$16.39M$0.1043.15IBEX$535.67M0.73$33.65M$2.2912.85 Which has more risk and volatility, GDRX or IBEX? GoodRx has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Comparatively, IBEX has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Do analysts recommend GDRX or IBEX? GoodRx presently has a consensus price target of $5.80, suggesting a potential upside of 34.41%. IBEX has a consensus price target of $27.00, suggesting a potential downside of 8.26%. Given GoodRx's stronger consensus rating and higher possible upside, research analysts plainly believe GoodRx is more favorable than IBEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GoodRx 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45IBEX 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders have more ownership in GDRX or IBEX? 63.8% of GoodRx shares are held by institutional investors. Comparatively, 81.2% of IBEX shares are held by institutional investors. 4.5% of GoodRx shares are held by insiders. Comparatively, 6.7% of IBEX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryGoodRx and IBEX tied by winning 8 of the 16 factors compared between the two stocks. Get IBEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IBEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBEX vs. The Competition Export to ExcelMetricIBEXBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$393.54M$5.65B$25.95B$9.75BDividend YieldN/A3.35%2.78%4.02%P/E Ratio12.8529.4928.0826.36Price / Sales0.731.811,126.24155.09Price / Cash9.2016.7726.8459.42Price / Book3.064.836.176.57Net Income$33.65M$155.37M$196.88M$265.92M7 Day Performance-2.61%2.40%8.41%0.06%1 Month Performance-2.68%4.91%6.03%1.99%1 Year Performance69.24%60.63%45.42%20.91% IBEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBEXIBEX1.5122 of 5 stars$29.43-0.3%$27.00-8.3%+70.7%$393.54M$535.67M12.8530,000GDRXGoodRx2.9742 of 5 stars$4.25-6.8%$5.80+36.5%-47.3%$1.58B$792.32M42.50950FLYWFlywire1.4666 of 5 stars$12.84+0.2%$13.71+6.8%-23.9%$1.57B$492.14M256.801,250Options VolumeTASKTaskUs2.0085 of 5 stars$17.41+0.2%$17.40-0.1%+29.3%$1.56B$994.98M25.2348,200DFINDonnelley Financial Solutions3.4614 of 5 stars$56.19-0.1%$71.33+27.0%-13.5%$1.55B$781.90M19.861,800Positive NewsInsider TradeNVEENV5 Global1.6414 of 5 stars$22.56flat$25.67+13.8%N/A$1.51B$941.27M45.585,024GBGlobal Blue Group1.8281 of 5 stars$7.49+0.1%$6.00-19.9%+52.5%$1.49B$545.29M20.242,160STGWStagwell3.2657 of 5 stars$5.61-2.4%$8.17+45.7%-22.4%$1.49B$2.84B12.2314,607UPBDUpbound Group4.5565 of 5 stars$25.21-0.1%$34.50+36.9%-22.7%$1.46B$4.32B14.1611,970Positive NewsPLTKPlaytika4.1101 of 5 stars$3.72-0.5%$7.04+89.1%-51.4%$1.41B$2.55B15.503,500Positive NewsCRTOCriteo4.2149 of 5 stars$23.81-1.6%$40.00+68.0%-47.2%$1.40B$1.93B9.963,507 Related Companies and Tools Related Companies GDRX Competitors FLYW Competitors TASK Competitors DFIN Competitors NVEE Competitors GB Competitors STGW Competitors UPBD Competitors PLTK Competitors CRTO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IBEX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access